NOV 08, 2017
Ranibizumab in ROP
Pediatric Ophthalmology Subspecialty Day 2016
03:52
Pediatric Ophth/Strabismus, Vitreoretinal Diseases
In this presentation from Pediatric Subspecialty Day 2016, Dr. David Morrison makes the case that, although cost is an issue when considering the use of ranibizumab, there are many benefits to its use.